Loading...
Last submissions
-
-
-
Justine Gantzer, Guillaume Davidson, Bujamin Vokshi, Noëlle Weingertner, Antoine Bougoüin, et al.. Immune-Desert Tumor Microenvironment in Thoracic SMARCA4-Deficient Undifferentiated Tumors with Limited Efficacy of Immune Checkpoint Inhibitors. Oncologist, 2022, ⟨10.1093/oncolo/oyac040⟩. ⟨hal-03623495⟩
-
-
-
Julia Viard, Yann Loe-Mie, Rachel Daudin, Malik Khelfaoui, Christine Plancon, et al.. Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease. Life Science Alliance, 2022, 5 (12), ⟨10.26508/lsa.202101205⟩. ⟨hal-04219180⟩
-
-
-
Salma Darwish, Ehab Ghazy, Tino Heimburg, Daniel Herp, Patrik Zeyen, et al.. Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity. International Journal of Molecular Sciences, 2022, 23 (14), ⟨10.3390/ijms23147535⟩. ⟨hal-04219177⟩
-
-
-
-
-
Hamid Meziane, Marie-Christine Birling, Olivia Wendling, Sophie Leblanc, Aline Dubos, et al.. Large-Scale Functional Assessment of Genes Involved in Rare Diseases with Intellectual Disabilities Unravels Unique Developmental and Behaviour Profiles in Mouse Models. Biomedicines, 2022, 10 (12), ⟨10.3390/biomedicines10123148⟩. ⟨hal-04219164⟩
-
-
-
Gisele Fernanda Assine Picchi-Constante, Priscila Mazzocchi Hiraiwa, Martin Marek, Vanessa Zulkievicz Rogerio, Eloise Pavão Guerra-Slompo, et al.. Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in Trypanosoma cruzi. STAR Protocols, 2022, 3 (2), ⟨10.1016/j.xpro.2022.101324⟩. ⟨hal-04219152⟩
-
Ping Sun, Jing Wang, Khadija S. Khan, Weiqin Yang, Billy Wai-Lung Ng, et al.. Development of Alkylated Hydrazides as Highly Potent and Selective Class I Histone Deacetylase Inhibitors with T cell Modulatory Properties. Journal of Medicinal Chemistry, 2022, 65 (24), pp.16313-16337. ⟨10.1021/acs.jmedchem.2c01132⟩. ⟨hal-04219149⟩
-
-